Explore

Search ClinicalTrials.gov

Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.

Find trials by sponsor or company

Search by sponsors

RecruitingPhase IIIPhase III recruiting

StatusPhaseStudy typeSort

Results for “AstraZeneca”

A Study of Durvalumab (MEDI4736) in Esophageal CancerCompleted
NCT02639065Phase 2Updated Sep 25, 2023
Sponsor: Shadia Jalal, MD
Esophageal Cancer
United States
Osimertinib and Bevacizumab as Treatment for EGFR-mutant Lung CancersCompleted
NCT02803203Phase 1, Phase 2Updated Sep 22, 2023
Sponsor: Memorial Sloan Kettering Cancer Center
Non-small Cell Lung Cancer · EGFR-mutant Lung Cancers
United States
A Study to Evaluate the Safety of MEDI8897 for the Prevention of Medically Attended Respiratory Syncytial Virus(RSV) Lower Respiratory Track Infection (LRTI) in High-risk ChildrenCompleted
NCT03959488Phase 2, Phase 3Updated Sep 21, 2023
Sponsor: AstraZeneca
Respiratory Syncytial Virus Infections
United States, Austria, Belgium, Bulgaria, Canada +21 more
Olaparib in gBRCA Mutated Pancreatic Cancer Whose Disease Has Not Progressed on First Line Platinum-Based ChemotherapyCompleted
NCT02184195Phase 3Updated Sep 13, 2023
Sponsor: AstraZeneca
Germline BRCA1/2 Mutations and · Metastatic Adenocarcinoma of the Pancreas
United States, Australia, Belgium, Canada, France +7 more
Durvalumab and Standard Chemotherapy Before Surgery in Treating Patients With Variant Histology Bladder CancerTerminated
NCT03912818Phase 2Updated Sep 11, 2023
Sponsor: Stanford University
Bladder Adenocarcinoma · Bladder Mixed Adenocarcinoma · Bladder Squamous Cell Carcinoma · Bladder Urothelial Carcinoma
United States
Retrospective Study to Describe the Real-world Treatment Patterns and Associated Clinical Outcomes in Patients With Metastatic Castration-resistant Prostates CancerCompleted
NCT04801186N/AUpdated Sep 7, 2023
Sponsor: AstraZeneca
Metastatic Castration-resistant Prostates Cancer
Colombia, Egypt, India, Peru, Saudi Arabia +3 more
A Study to Determine Safety and Immunogenicity of the Candidate COVID-19 Vaccine AZD1222 Delivered by Aerosol in Healthy Adult VolunteersUnknown
NCT05007275Phase 1Updated Sep 6, 2023
Sponsor: Imperial College London
Covid19 · SARS-CoV-2 Infection
United Kingdom
Real-life Data of Olaparib in Relapsed Ovarian Cancers PatientsCompleted
NCT04152941N/AUpdated Sep 6, 2023
Sponsor: ARCAGY/ GINECO GROUP
Relapsed Ovarian Cancers Patients
France
Markers of COPD ExacerbationsUnknown
NCT05315674N/AUpdated Sep 6, 2023
Sponsor: Center of Expertise for Chronic Organ Failure
COPD · COPD Exacerbation
Netherlands
RELEVANCE - RWE Study in Unresectable Non-Small Cell Lung Cancer (Stage III) in CanadaCompleted
NCT05933044N/AUpdated Sep 5, 2023
Sponsor: AstraZeneca
Non-small Cell Lung Cancer
Canada
ChAracterisation of ItaliaN Severe Uncontrolled Asthmatic patieNts Key Features When Receiving BenralizumabCompleted
NCT04272463N/AUpdated Aug 31, 2023
Sponsor: AstraZeneca
Severe Asthma
Italy
Intermittent Selumetinib for Uveal MelanomaCompleted
NCT02768766Phase 1Updated Aug 31, 2023
Sponsor: Shaheer A. Khan
Uveal Melanoma
United States
Feasibility & Efficacy of Durvalumab+Tremelimumab+RT and Durvalumab+RT in Non-resect. Locally Advanced HPVnegativ HNSCCCompleted
NCT03624231Phase 2Updated Aug 31, 2023
Sponsor: Ulrich Keilholz
Squamous Cell Carcinoma of the Head and Neck
Germany
Efficacy and Safety Study of the Use of Benralizumab for Patients With Moderate to Severe Atopic DermatitisTerminated
NCT04605094Phase 2Updated Aug 31, 2023
Sponsor: AstraZeneca
Atopic Dermatitis
United States, Australia, Bulgaria, Czechia, France +3 more
A Study to Investigate the Safety, Tolerability and Effects of AZD8630 in Healthy Subjects and Subjects With Asthma on Inhaled Corticosteroids and Long-acting Beta-agonistsCompleted
NCT05110976Phase 1Updated Aug 30, 2023
Sponsor: AstraZeneca
Asthma
United States, Germany, United Kingdom
Effectiveness of Covid-19 Vaccination in Eswatini Against SARS-CoV-2 Associated Hospitalization and DeathCompleted
NCT04914832Phase 4Updated Aug 29, 2023
Sponsor: Shabir Madhi
COVID-19 · Pneumonia, Viral
Eswatini
A Study to Assess the Effects of Fluvoxamine on Savolitinib Exposure in Healthy Male SubjectsCompleted
NCT05888207Phase 1Updated Aug 29, 2023
Sponsor: AstraZeneca
Healthy Male Subjects
United States
Optimisation of ASthma In Those With Uncontrolled Symptoms (OASIS)Completed
NCT04941001NAUpdated Aug 28, 2023
Sponsor: Guy's and St Thomas' NHS Foundation Trust
Asthma · Asthma Attack · Asthma Persistent · Covid19
United Kingdom
A Study of Durvalumab Plus Tremelimumab With Chemotherapy in Untreated ES-SCLCTerminated
NCT03963414Phase 1Updated Aug 28, 2023
Sponsor: University of Nebraska
Small Cell Lung Carcinoma
United States
Identification of Disease Specific Pathways and Modifiers in Phospholamban R14del CardiomyopathyCompleted
NCT04978987N/AUpdated Aug 25, 2023
Sponsor: University Medical Center Groningen
Phospholamban R14del Cardiomyopathy · Heart Failure · Cardiomyopathy, Familial
Netherlands
ACTIV-3: Therapeutics for Inpatients With COVID-19Completed
NCT04501978Phase 3Updated Aug 25, 2023
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Covid19
United States, Denmark, Greece, Nigeria, Poland +5 more
Phase 1 Study to Determine the Metabolism and Clearance of BaxdrostatCompleted
NCT05961384Phase 1Updated Aug 15, 2023
Sponsor: AstraZeneca
Hypertension
United States
Baxdrostat Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Study in a Japanese PopulationCompleted
NCT05966324Phase 1Updated Aug 14, 2023
Sponsor: AstraZeneca
Hypertension
United States
Phase 1 PK Study to Evaluate the PK of CIN-107 in Subjects With Hepatic ImpairmentCompleted
NCT05961397Phase 1Updated Aug 14, 2023
Sponsor: AstraZeneca
Hypertension
United States
A Study of Adavosertib as Treatment for Uterine Serous CarcinomaCompleted
NCT04590248Phase 2Updated Aug 14, 2023
Sponsor: AstraZeneca
Uterine Serous Carcinoma
United States, Canada, France, Italy, Spain

Previous page Next page